Investorideas.com
Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 


Investorideas podcasts on iTunes, Google Play Music and iHeart.com    Investorideas.com potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts    Investorideas.com crypto corner    Play by Play – the latest sports headlines and sports stock news    420 Cannabis Investor Ideas

 

Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

#MedicalMarijuana Market worth over $55 billion by 2024

Medical Marijuana Market By Application, By Route of Administration, By Distribution Channel & Regional Analysis covering 15+ Countries and 16 Company Profiles (Canopy Growth, Aphria, Inc., Aurora Cannabis, Inc., GW Pharmaceuticals, 9mCig, Medical Marijuana, Inc., United Cannabis, MedReleaf, The Supreme Cannabis Company, CanniMed Ltd., Medical Marijuana, Inc., Tilray, Emerald Health Therapeutics, Lexaria Corporation, Cannabis Sativa, Inc., Insys Therapeutics, Inc., Corbus Pharmaceuticals, GBSciences, Inc., The Cronos Group, The Hydropothecary Corporation, Namaste Technologies Inc. ), Global Forecasts to 2024

 

Sellbyville, Delaware - August 22, 2018 (Investorideas.com Newswire) Global Medical Marijuana Market outlook is projected to surpass USD 55 billion by 2024, says a new Global Market Insights, Inc. report featuring key industry trends across the application, route of administration, distribution channel, and regional landscape.

The extensive demand for marijuana in the treatment of chronic pain due to cancer, arthritis, HIV/AIDS, and cancer will foster the global medical marijuana market growth. The rising inclination toward marijuana as opposed to opioid narcotics will also influence the industry trends.

According to the report, medical marijuana market size from dispensaries is foreseen to exhibit a double-digit CAGR of 36.2% over 2018-2024. Powered by the increasing number of dispensaries set up in myriad regions and growth in the legal sale of medical marijuana have optimistically influenced and proliferated the segment growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2836

In terms of the regional landscape, Canada medical marijuana industry is projected to witness 32% CAGR over 2018-2024. The country has completely legalized the sale, production, & consumption of medical marijuana and is thus witnessing robust product sales. Presence of prominent marijuana companies in the region is also expected to drive the regional share.

The key players profiled in the report are GW Pharmaceuticals, Aphria, Aurora Cannabis Inc., Canopy Growth Corporation, Medical Marijuana, Inc., Supreme Cannabis Company Inc., MedReleaf, CanniMed Therapeutics Inc., Lexaria Corporation, Tilray, United Cannabis Corporation, Emerald Health Therapeutics, Cannabis Sativa, Inc., Cronos Group, GBSciences, Inc., The Hydropothecary Corporation, Corbus Pharmaceuticals, Namaste Technologies, and Insys Therapeutics, Inc. The companies have been profiled in terms of their strategic outlook, product portfolio, and SWOT assessment.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2836

Scope of the Medical Marijuana Market report:

  • Application landscape: Pain Management (Cancer Pain, Neuropathic Pain), Muscle Spasms, Nausea, Anorexia, Seizures, Others
  • Route of administration landscape: Inhalation, Oral, Topical
  • Distribution channel landscape: Dispensaries, Online
  • Regional landscape: Canada, U.S., UK, Germany, Czech Republic, France, Italy, The Netherlands, Chile, Peru, Argentina, Colombia, Israel, Australia

Browse key industry insights spread across 150 pages with 161 market data tables & 9 figures & charts from the report, "Medical Marijuana Market" in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/medical-marijuana-market

Partial Table of Contents (ToC) of the report:

Chapter 2. Executive Summary

2.1. Medical marijuana industry 3600 synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Application trends

2.1.3. Route of administration trends

2.1.4. Distribution channel trends

2.1.5. Regional trends

Chapter 3. Medical Marijuana Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 – 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Increasing application of marijuana for a myriad of medical conditions and symptoms

3.3.1.2. Growing demand for medical marijuana legalization in several countries

3.3.1.3. Rising number of R&D and clinical trial activities

3.3.2. Industry pitfalls & challenges

3.3.2.1. Few side effects might hinder the market growth

3.3.2.2. Difficulty in medical marijuana business banking

3.4. Growth potential analysis

3.4.1. By application

3.4.2. By route of administration

3.4.3. By distribution channel

3.5. Porter's analysis

3.6. Competitive landscape, 2017

3.6.1. Business overview

3.6.2. Revenue analysis

3.6.3. Product landscape

3.6.4. Strategy dashboard

3.7. PESTEL analysis

3.8. Value chain analysis

3.9. Legal Requirement for Distribution of Medical Marijuana

3.10. Regulatory Landscape, by Country

3.10.1. US

3.10.2. Canada

3.10.3. The Netherlands

3.10.4. Israel

Chapter 4. Medical Marijuana Market, By Application

4.1. Global medical marijuana market share, by application, 2017 & 2024

4.2. Pain Management

4.2.1. Market estimates and forecast, by region, 2013 – 2024

4.2.2. Neuropathic Pain

4.2.2.1. Market estimates and forecast, by region, 2013 – 2024

4.2.3. Cancer Pain

4.2.3.1. Market estimates and forecast, by region, 2013 – 2024

4.2.4. Others

4.2.4.1. Market estimates and forecast, by region, 2013 – 2024

4.3. Muscle Spasms

4.3.1. Market estimates and forecast, by region, 2013 – 2024

4.4. Nausea

4.4.1. Market estimates and forecast, by region, 2013 - 2024

4.5. Anorexia

4.5.1. Market estimates and forecast, by region, 2013 - 2024

4.6. Seizures

4.6.1. Market estimates and forecast, by region, 2013 - 2024

4.7. Others

4.7.1. Market estimates and forecast, by region, 2013 – 2024

Browse Full ToC @ https://www.gminsights.com/toc/detail/medical-marijuana-market

Browse Related Reports:

Fibromyalgia Treatment Market Size 2018-2024

Fibromyalgia Treatment Market revenue is projected to experience significant growth from 2018 to 2024. Rising burden of chronic pain due to rheumatic conditions across the globe will drive fibromyalgia treatment market growth over the forecast timeline. Reoccurrence of rheumatic arthritis leads to fibromyalgia syndrome.

https://www.gminsights.com/industry-analysis/fibromyalgia-treatment-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://www.cmferesearch.com/



Marijuana / Hemp Stocks

Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks


More Info:

Investorideas.com Newswire

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp